[보안 로그인 하기]
[회원가입]  [ID/PW찾기]
대한민국 원환율 (2021-04-22)
통화 금액
USD 1,116
EUR 1,343
GBP 1,555
JPY 1,033
CAD 892
Onco-Nephrology
Onco-Nephrology
       판매가 : 240,000216,000
       적립금 : 4,320
       저   자 : Finkel
       역   자 :
       출판사 : Elsevier
    ISBN(13) : 9780323549455
       발행일 : 2019-09-02  /   판   /   384 페이지
       상품코드 : 27241
       수 량 :
       

Description


Kidney disease and cancer are frequent comorbidities that require specialized knowledge and expertise from both
the nephrologist and the oncologist. Written by three pioneers in this growing subspecialty, Onco-Nephrology
provides authoritative, definitive coverage of the mechanism and management of these two life-threatening diseases.
This unique, single-volume resource covers current protocols and recommends management therapies to arrest kidney
failure and allow oncologic treatments to continue and succeed.
  • Addresses acute and chronic kidney diseases that develop from a variety of cancers. This includes direct kidney
    injury from the malignancy, paraneoplastic effects of the cancer, and various cancer agents used to treat the
    malignancy.
  • Discusses key issues regarding kidney disease in patients with cancer, including conventional chemotherapeutic
    regimens and new novel therapies (targeted agents and immunotherapies) or the malignancies themselves that may promote
    kidney injury; patients with chronic kidney disease who acquire cancer unrelated to renal failure; and kidney
    transplantation, which has been shown to carry an increased risk of cancer.
  • Contains dedicated chapters for each class of the conventional chemotherapeutic agents, targeted cancer agents, and
    cancer immunotherapies including the basic science, pathogenic mechanisms of injury, clinical manifestations, and
    treatment.

  • 더보기

  • Includes special chapters devoted to the individual classes of chemotherapies that relate to kidney disease for
    quick reference. Discusses increasingly complex problems due to more numerous and specialized anti-cancer drugs, as
    well as increased survival rates for both cancer and renal failure requiring long-term patient care.
  • Covers anti-VEGF (antivascular endothelial growth factor) agents and cancer immunotherapies – treatments that are
    being recognized for adverse kidney effects.
  • Utilizes a clear, logical format based on the ASN Core Curriculum for Onco-Nephrology, making this reference an
    excellent tool for board review, as well as a practical resource in daily practice.




  • SECTION 1. Fluid and Electrolyte Disorders in Cancer Patients
    1. Kidney function
    2. Dysnatremias in cancer
    3. Potassium disorders
    4. Calcium and phosphorus disorders
    5. Volume disorders and fluid resuscitation

    SECTION 2. Paraprotein-Related Kidney Diseases
    6. Paraproteins
    7. Cast nephropathy
    8. Systemic light chain amyloidosis
    9. Monoclonal immunoglobulin deposition disease
    10. Fibrillary and immunotactoid glomerulonephritis

    SECTION 3. Hematopoietic Stem Cell Associated Kidney Disease
    11. Hematopoietic cell transplant associated kidney injury
    12. Sinusoidal obstruction syndrome
    13. Thrombotic microangiopathy
    14. Graft-versus-host disease
    15. Chronic kidney disease, end-stage renal disease, and bone marrow transplant

    SECTION 4. Chemotherapy and Radiation Related Kidney Diseases
    16. Conventional chemotherapy
    17. Targeted cancer therapies (biologics)
    18. Adverse kidney effects of immunotherapies
    19. Chemotherapy in chronic kidney disease and dialysis
    20. Radiation nephropathy

    SECTION 5. Paraneoplastic Glomerulopathies
    21. Paraneoplastic glomerular diseases
    22. Paraneoplastic glomerulonephritis
    23. Hematologic malignancies
    24. Cancer screening recommendations

    SECTION 6. Renal Tumors
    25. Renal cell cancer
    26. Wilms tumor and von Hippel Lindau disease
    27. Tuberous sclerosis complex and the kidney
    28. Evaluation of a renal cyst/mass

    SECTION 7. Acute Kidney Injury
    29. Acute kidney injury incidence, pathogenesis, and outcomes
    30. Tumor lysis syndrome
    31. Obstructive nephropathy in cancer
    32. Renal replacement therapies

    SECTION 8. Chronic Kidney Disease and Cancer
    33. Chronic kidney disease as a complication of cancer, with special focus on kidney and urothel
    34. Incidence of cancer and screening recommendations
    35. Cancer in renal transplant patients

    SECTION 9. Kidney Infections
    36. Renal infections in cancer patients

    SECTION 10. Infiltrative Diseases
    37. Kidney disease in leukemia
    38. Kidney disease in lymphoma

    Index
    클릭 하시면 에스크로 가입여부를 확인 하실 수 있습니다.